Gunther Birznieks is a seasoned pharmaceutical executive currently serving as the Senior Vice President of Business Development at Vanda Pharmaceuticals Inc. With an extensive background in the biopharmaceutical industry, Birznieks has dedicated his career to driving innovation and growth within the sector. Prior to joining Vanda, he held various leadership positions at several prominent companies, including Eli Lilly and Company, where he honed his skills in business development, strategic planning, and corporate strategy. His expertise in these areas has been instrumental in his success at Vanda, where he leads efforts to identify and capitalize on new opportunities that align with the company's mission to develop novel therapies for patients with unmet medical needs. At Vanda Pharmaceuticals, Birznieks plays a pivotal role in shaping the company's growth strategy. He is responsible for overseeing the identification, evaluation, and execution of business development initiatives, including licensing agreements, collaborations, and acquisitions. Under his leadership, Vanda has successfully expanded its pipeline and strengthened its position in the competitive pharmaceutical market. Birznieks' strategic vision and ability to forge strong partnerships have been key factors in the company's continued success. His contributions have not only driven the growth of Vanda's portfolio but have also enhanced the company's reputation as a leader in the development of innovative treatments for central nervous system disorders and other serious medical conditions.